Can the Magnificent 7 ETF Keep Surging?

Can the Magnificent 7 ETF Keep Surging?

Roundhill’s Mazza talks Mag 7 stocks, GLP-1 drugs, online gambling and the metaverse.

Exchange
Reviewed by: etf.com Staff
,
Edited by: Kent Thune
Podcast icon

The Roundhill Magnificent Seven ETF (MAGS) is up a whopping 33% so far this year, double the 15.5% gain for the S&P 500. 

But can Mag 7-heavy exchange-traded funds keep soaring, especially now that the market is the most concentrated it’s been in decades?  

Dave Mazza, Chief Executive Officer at Roundhill Investments, sits down with etf.com Senior Analyst Sumit Roy to discuss.

In addition to Mag 7 stocks, Mazza touches on the boom in GLP-1 drugs and online gambling. He also gets into whether the metaverse is a theme that will eventually take of

Join etf.com writers and special guests for a weekly dose of what's going on in markets and the ETF world! From the latest trends to breaking news, our experts will discuss everything you need to know about investing in ETFs.

LISTEN AND SUBSCRIBE ON: Apple Podcast | Spotify